The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients

作者全名："Wang, Zicheng; Li, Jiayi; Zhang, Peizhi; Zhao, Leizuo; Huang, Bingyin; Xu, Yingkun; Wu, Guangzhen; Xia, Qinghua"

作者地址："[Wang, Zicheng; Xia, Qinghua] Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan, Peoples R China; [Wang, Zicheng; Xia, Qinghua] Shandong First Med Univ & Shandong Acad Med Sci, Med Sci & Technol Innovat Ctr, Jinan, Peoples R China; [Li, Jiayi] Hanyang Univ, Sch Business, Seoul, South Korea; [Zhang, Peizhi; Zhao, Leizuo; Xia, Qinghua] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Urol, Jinan, Peoples R China; [Zhao, Leizuo] Dongying Peoples Hosp, Dept Urol, Dongying, Peoples R China; [Huang, Bingyin] First Peoples Hosp Zhoukou, Dept Pathol, Zhoukou, Peoples R China; [Xu, Yingkun] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China; [Wu, Guangzhen] Dalian Med Univ, Affiliated Hosp 1, Dept Urol, Dalian, Peoples R China"

通信作者："Xia, QH (通讯作者)，Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan, Peoples R China.; Xia, QH (通讯作者)，Shandong First Med Univ & Shandong Acad Med Sci, Med Sci & Technol Innovat Ctr, Jinan, Peoples R China.; Xia, QH (通讯作者)，Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Urol, Jinan, Peoples R China."

来源：FRONTIERS IN GENETICS

ESI学科分类：MOLECULAR BIOLOGY & GENETICS

WOS号：WOS:000831253900001

JCR分区：Q2

影响因子：3.7

年份：2022

卷号：13

期号：　

开始页：　

结束页：　

文献类型：Article

关键词：TCGA; KIRC; ERBB signaling pathway; pan-cancer; GDSC

摘要："Objective: We aimed to investigate the potential role of ERBB signaling pathway-related genes in kidney renal clear cell carcinoma (KIRC) and establish a new predictive risk model using various bioinformatics methods.Methods: We downloaded the KIRC dataset and clinicopathological information from The Cancer Genome Atlas database. Univariate Cox analysis was used to identify essential genes significantly associated with KIRC progression. Next, we used the STRING website to construct a protein-protein interaction network of ERBB signaling pathway-related molecules. We then used the least the absolute shrinkage and selection operator (LASSO) regression analysis to build a predictive risk model for KIRC patients. Next, we used multiple bioinformatics methods to analyze the copy number variation, single-nucleotide variation, and overall survival of these risk model genes in pan-cancer. At last, we used the Genomics of Drug Sensitivity in Cancer to investigate the correlation between the mRNA expression of genes associated with this risk model gene and drug sensitivity.Results: Through the LASSO regression analysis, we constructed a novel KIRC prognosis-related risk model using 12 genes: SHC1, GAB1, SOS2, SRC, AKT3, EREG, EIF4EBP1, ERBB3, MAPK3, transforming growth factor-alpha, CDKN1A, and PIK3CD. Based on this risk model, the overall survival rate of KIRC patients in the low-risk group was significantly higher than that in the high-risk group (p = 1.221 x 10(-15)). Furthermore, this risk model was associated with cancer metastasis, tumor size, node, stage, grade, sex, and fustat in KIRC patients. The receiver operating characteristic curve results showed that the model had better prediction accuracy. Multivariate Cox regression analysis showed that the model's risk score was an independent risk factor for KIRC. The Human Protein Atlas database was used to validate the protein expression of risk model-associated molecules in tumors and adjacent normal tissues. The validation results were consistent with our previous findings.Conclusions: We successfully established a prognostic-related risk model for KIRC, which will provide clinicians with a helpful reference for future disease diagnosis and treatment."

基金机构：　

基金资助正文：